DE102007022694A1 - Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme - Google Patents
Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme Download PDFInfo
- Publication number
- DE102007022694A1 DE102007022694A1 DE102007022694A DE102007022694A DE102007022694A1 DE 102007022694 A1 DE102007022694 A1 DE 102007022694A1 DE 102007022694 A DE102007022694 A DE 102007022694A DE 102007022694 A DE102007022694 A DE 102007022694A DE 102007022694 A1 DE102007022694 A1 DE 102007022694A1
- Authority
- DE
- Germany
- Prior art keywords
- calcium
- milk
- composition according
- milk fat
- fat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 235000021243 milk fat Nutrition 0.000 title claims abstract description 46
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 102000014171 Milk Proteins Human genes 0.000 title claims abstract description 26
- 108010011756 Milk Proteins Proteins 0.000 title claims abstract description 26
- 235000021239 milk protein Nutrition 0.000 title claims abstract description 26
- 239000011575 calcium Substances 0.000 title claims description 63
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims description 62
- 229910052791 calcium Inorganic materials 0.000 title claims description 62
- 238000010521 absorption reaction Methods 0.000 title description 8
- 230000007062 hydrolysis Effects 0.000 claims abstract description 9
- 238000006460 hydrolysis reaction Methods 0.000 claims abstract description 9
- 229960005069 calcium Drugs 0.000 claims description 61
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 32
- 239000000047 product Substances 0.000 claims description 29
- 239000008267 milk Substances 0.000 claims description 25
- 235000013336 milk Nutrition 0.000 claims description 24
- 210000004080 milk Anatomy 0.000 claims description 24
- 235000021314 Palmitic acid Nutrition 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 15
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 15
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 12
- 239000003995 emulsifying agent Substances 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 235000015872 dietary supplement Nutrition 0.000 claims description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 159000000007 calcium salts Chemical class 0.000 claims description 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001736 Calcium glycerylphosphate Substances 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 230000000996 additive effect Effects 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 229960003563 calcium carbonate Drugs 0.000 claims description 2
- 235000010216 calcium carbonate Nutrition 0.000 claims description 2
- 239000001110 calcium chloride Substances 0.000 claims description 2
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 2
- 229960002713 calcium chloride Drugs 0.000 claims description 2
- 235000011148 calcium chloride Nutrition 0.000 claims description 2
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 2
- 239000001354 calcium citrate Substances 0.000 claims description 2
- 229960004256 calcium citrate Drugs 0.000 claims description 2
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 2
- 239000004227 calcium gluconate Substances 0.000 claims description 2
- 229960004494 calcium gluconate Drugs 0.000 claims description 2
- 235000013927 calcium gluconate Nutrition 0.000 claims description 2
- 229940095618 calcium glycerophosphate Drugs 0.000 claims description 2
- UHHRFSOMMCWGSO-UHFFFAOYSA-L calcium glycerophosphate Chemical compound [Ca+2].OCC(CO)OP([O-])([O-])=O UHHRFSOMMCWGSO-UHFFFAOYSA-L 0.000 claims description 2
- 235000019299 calcium glycerylphosphate Nutrition 0.000 claims description 2
- 239000000920 calcium hydroxide Substances 0.000 claims description 2
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 2
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 2
- 239000001527 calcium lactate Substances 0.000 claims description 2
- 229960002401 calcium lactate Drugs 0.000 claims description 2
- 235000011086 calcium lactate Nutrition 0.000 claims description 2
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 claims description 2
- 239000000292 calcium oxide Substances 0.000 claims description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 claims description 2
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 2
- 239000000835 fiber Substances 0.000 claims description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 2
- 229940068065 phytosterols Drugs 0.000 claims description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 2
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 230000003185 calcium uptake Effects 0.000 abstract 1
- 235000001465 calcium Nutrition 0.000 description 59
- 108010076119 Caseins Proteins 0.000 description 22
- 102000011632 Caseins Human genes 0.000 description 22
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 20
- 235000021240 caseins Nutrition 0.000 description 20
- 235000013365 dairy product Nutrition 0.000 description 18
- 108010067454 caseinomacropeptide Proteins 0.000 description 16
- 108010046377 Whey Proteins Proteins 0.000 description 14
- 229940021722 caseins Drugs 0.000 description 13
- 235000018102 proteins Nutrition 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 108090000623 proteins and genes Proteins 0.000 description 10
- 235000021119 whey protein Nutrition 0.000 description 10
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 8
- 239000000194 fatty acid Substances 0.000 description 8
- 229930195729 fatty acid Natural products 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 239000005018 casein Substances 0.000 description 7
- 235000019871 vegetable fat Nutrition 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 102000007544 Whey Proteins Human genes 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 102000005701 Calcium-Binding Proteins Human genes 0.000 description 5
- 108010045403 Calcium-Binding Proteins Proteins 0.000 description 5
- 235000020247 cow milk Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 4
- 235000011941 Tilia x europaea Nutrition 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000002349 favourable effect Effects 0.000 description 4
- 235000020256 human milk Nutrition 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 210000000936 intestine Anatomy 0.000 description 4
- 239000004571 lime Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000344 soap Substances 0.000 description 4
- 238000005809 transesterification reaction Methods 0.000 description 4
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 230000002378 acidificating effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000014121 butter Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000004251 human milk Anatomy 0.000 description 3
- 239000011777 magnesium Substances 0.000 description 3
- 229910052749 magnesium Inorganic materials 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 3
- 235000015112 vegetable and seed oil Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000001132 Osteoporosis Diseases 0.000 description 2
- -1 aromatic amino acid Chemical class 0.000 description 2
- 235000008452 baby food Nutrition 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 150000001720 carbohydrates Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 235000013350 formula milk Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000005194 fractionation Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 235000006486 human diet Nutrition 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 235000013618 yogurt Nutrition 0.000 description 2
- 235000021246 κ-casein Nutrition 0.000 description 2
- BUHVIAUBTBOHAG-FOYDDCNASA-N (2r,3r,4s,5r)-2-[6-[[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol Chemical compound COC1=CC(OC)=CC(C(CNC=2C=3N=CN(C=3N=CN=2)[C@H]2[C@@H]([C@H](O)[C@@H](CO)O2)O)C=2C(=CC=CC=2)C)=C1 BUHVIAUBTBOHAG-FOYDDCNASA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 235000006008 Brassica napus var napus Nutrition 0.000 description 1
- 240000000385 Brassica napus var. napus Species 0.000 description 1
- 241000282836 Camelus dromedarius Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 241000208818 Helianthus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 241001408665 Timandra griseata Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 150000001413 amino acids Chemical group 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 229940108924 conjugated linoleic acid Drugs 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000011850 desserts Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000008410 fruit bars Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001497 healthy food Nutrition 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 235000021125 infant nutrition Nutrition 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 108010028463 kappa-casein glycomacropeptide Proteins 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229940108461 rennet Drugs 0.000 description 1
- 108010058314 rennet Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 235000021003 saturated fats Nutrition 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 238000007391 self-medication Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C21/00—Whey; Whey preparations
- A23C21/06—Mixtures of whey with milk products or milk components
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/20—Dietetic milk products not covered by groups A23C9/12 - A23C9/18
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/20—Milk; Whey; Colostrum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Emergency Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007022694A DE102007022694A1 (de) | 2007-05-11 | 2007-05-11 | Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme |
CN200880015561A CN101686726A (zh) | 2007-05-11 | 2008-05-07 | 用于改善钙吸收的乳脂-乳蛋白组合物(优选用棕榈酸酯化) |
EP08750120A EP2152101A1 (de) | 2007-05-11 | 2008-05-07 | Milchfett-milchprotein-zusammensetzung (vorzugsweise verestert mit palmitinsäure) zur verbesserung der calcium-aufnahme |
RU2009144036/13A RU2468610C2 (ru) | 2007-05-11 | 2008-05-07 | Композиция молочного жира и молочного белка, предпочтительно этерифицированная пальмитиновой кислотой, для улучшения усвоения кальция |
CN201610173158.8A CN105962374A (zh) | 2007-05-11 | 2008-05-07 | 组合物的应用 |
PCT/EP2008/055597 WO2008138821A1 (de) | 2007-05-11 | 2008-05-07 | Milchfett-milchprotein-zusammensetzung (vorzugsweise verestert mit palmitinsäure) zur verbesserung der calcium-aufnahme |
UAA200911185A UA99614C2 (ru) | 2007-05-11 | 2008-05-07 | Комплекс молочного жира с молочными протеинами для улучшения усвоения кальция |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102007022694A DE102007022694A1 (de) | 2007-05-11 | 2007-05-11 | Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme |
Publications (1)
Publication Number | Publication Date |
---|---|
DE102007022694A1 true DE102007022694A1 (de) | 2008-11-13 |
Family
ID=39645456
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE102007022694A Ceased DE102007022694A1 (de) | 2007-05-11 | 2007-05-11 | Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2152101A1 (ru) |
CN (2) | CN105962374A (ru) |
DE (1) | DE102007022694A1 (ru) |
RU (1) | RU2468610C2 (ru) |
UA (1) | UA99614C2 (ru) |
WO (1) | WO2008138821A1 (ru) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016097220A1 (en) * | 2014-12-19 | 2016-06-23 | Nestec S.A. | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid |
WO2016097221A1 (en) * | 2014-12-19 | 2016-06-23 | Nestec S.A. | Infant nutrition with hydrolysed protein and palmitic acid |
NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
DE102019205767A1 (de) * | 2019-04-23 | 2020-10-29 | Beiersdorf Ag | Deodorant- oder Antitranspirantzusammensetzung |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1399244B1 (it) * | 2009-07-31 | 2013-04-11 | Pharmarte S R L | Formulazione di barretta specifica per la gravidanza. |
WO2012173467A1 (en) * | 2011-06-16 | 2012-12-20 | N.V. Nutricia | Metabolic imprinting effects of specifically designed lipid component |
WO2022122986A1 (en) | 2020-12-11 | 2022-06-16 | Frieslandcampina Nederland B.V. | Fat blend suitable for infant nutrition |
WO2023232962A1 (en) | 2022-06-02 | 2023-12-07 | Frieslandcampina Nederland B.V. | Fat blend suitable for infant nutrition |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037373A1 (en) * | 2003-10-22 | 2005-04-28 | Enzymotec Ltd. | A lipid preparation for enhancing mineral absorption |
WO2006114791A1 (en) * | 2005-04-27 | 2006-11-02 | Enzymotec Ltd. | Human milk fat substitutes |
DE102005033630A1 (de) | 2005-07-19 | 2007-01-25 | Humana Gmbh | Calcium-Peptid-Komponente |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2890379B2 (ja) * | 1990-08-28 | 1999-05-10 | 雪印乳業株式会社 | カルシウム吸収促進栄養剤、食品及び飼料 |
GB9217780D0 (en) * | 1992-08-21 | 1992-10-07 | Efamol Holdings | Fatty acid treatment |
NL9401958A (nl) * | 1994-11-23 | 1996-07-01 | Friesland Brands Bv | Met eierschalenmeel verrijkt melkprodukt. |
EP1062876A1 (en) * | 1999-02-25 | 2000-12-27 | Societe Des Produits Nestle S.A. | Caseinoglycomacropeptides as calcification agent |
US6620427B2 (en) * | 2001-04-24 | 2003-09-16 | Abbott Laboratories | Method for improving bone mineralization |
-
2007
- 2007-05-11 DE DE102007022694A patent/DE102007022694A1/de not_active Ceased
-
2008
- 2008-05-07 UA UAA200911185A patent/UA99614C2/ru unknown
- 2008-05-07 EP EP08750120A patent/EP2152101A1/de not_active Ceased
- 2008-05-07 CN CN201610173158.8A patent/CN105962374A/zh active Pending
- 2008-05-07 WO PCT/EP2008/055597 patent/WO2008138821A1/de active Application Filing
- 2008-05-07 CN CN200880015561A patent/CN101686726A/zh active Pending
- 2008-05-07 RU RU2009144036/13A patent/RU2468610C2/ru active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005037373A1 (en) * | 2003-10-22 | 2005-04-28 | Enzymotec Ltd. | A lipid preparation for enhancing mineral absorption |
WO2006114791A1 (en) * | 2005-04-27 | 2006-11-02 | Enzymotec Ltd. | Human milk fat substitutes |
DE102005033630A1 (de) | 2005-07-19 | 2007-01-25 | Humana Gmbh | Calcium-Peptid-Komponente |
Non-Patent Citations (21)
Title |
---|
(sondern überwiegend in der sn-1/sn-3) zu finden ist (Porsgaard, T. and Hoy, CE, J.Nutr. 130: 1619-1624 (2000); Weber, N. et al. J. Nutr. 133: 435-441 (2003)). |
Allred S.L. et al. J. Dairy Sci. 89: 234-248 (2006) |
Bell, J. A. et al. J. Dairy Sci. 89: 733-748 (2006) |
CARNIELLI, V.P. (u.a.): Structural position and amount of palmiticacid in infant formulas: effects on fat and mineral balance. In: J. Pediatr. Gastroenterol. Nutr. (1996), Vol. 23, Nr. 5, S. 553. (abstract) pubMed (online). (recherchiert am 13.11.2007). PMID 8985844.: |
CARNIELLI; V.P. (u.a.): Feeding premature newborn infants palmitic acid in amounts and stereo * |
CARNIELLI; V.P. (u.a.): Feeding premature newborn infants palmitic acid in amounts and stereo- |
DePeters E. J. et al. J. Dairy Sci. 84: 929-936 (2001) |
DIMICK, P.S. (u.a.): Structure and Synthesis of Milk Fat. VIII. Unique Positioning of Palmitic Acid in Milk Fat Triglycerides. In: J. Dairy Sci. (1965), Vol., 735. * |
FREEMAN, C.P. (u.a.): Intramolecular Fatty Acid Distribution in the Milk Fat Triglycerides of Several Species. In: J. Dairy Sci. (1965), Vol. 48, S. 853 * |
Handbuch der Milch- und Molkereitechnik, Verlag Th. Mann GmbH & Co. KG, 45894 Gelsenkirchen, 2003, S.412 |
Jacobsen, R.; Lorenzen, J. K.; Toubro, S.; Krog-Mikkelsen, I.; Astrup, A.; Intern. J. Obesity 29: 292-301 (2005) |
KENNEDY, K. (u.a.): Double-blind, randomized trial of a synthetic-triacylglycerol in formula-fed term infants: effects on stool biochemistry, stool characteristics, and bone mineralization. In: Am. J. Clin. Nutr. (1999), Vol. 70, S. 920. * |
Lai, H-C. et <?page 4?>al. J. Dairy Sci. 78: 794-803 (1995) |
LUCAS, A. (u.a.): Randomised controlled trial of a synthetic triglyceride milk formula for preterm infants. In: Arch. Dis. Child. (1997), Vol. 77, F.178-F184. * |
Lucas, A. et al. Arch. Dis. Child 77: F178-F184(1997 |
Nelson, CM and Innis SM. Am. J. Clin. Nutr. 70: 6-69(1999) |
Nielsen, T. S. et al. Reprod. Nutr. Dev. 46: 699-712 (2006) |
Ostrom KM. et al. J. Am Coll. Nutr. 21: 564-569(2002) |
Palmquist, D. L. et al. J. Dairy Sci. 76: 1753-1771 (1993) |
Porsgaard, T. and Hoy, CE, J. Nutr. 130: 1619-1624 (2000) |
someric position similar to that of human milk: effects on fat and mineral balance. In: Am. J. Clin. Nutr. (1995), Vol. 61, 1037. |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016097220A1 (en) * | 2014-12-19 | 2016-06-23 | Nestec S.A. | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid |
WO2016097221A1 (en) * | 2014-12-19 | 2016-06-23 | Nestec S.A. | Infant nutrition with hydrolysed protein and palmitic acid |
AU2015367306B2 (en) * | 2014-12-19 | 2019-08-08 | Société des Produits Nestlé S.A. | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid |
AU2015367307B2 (en) * | 2014-12-19 | 2019-08-08 | Société des Produits Nestlé S.A. | Infant nutrition with hydrolysed protein and palmitic acid |
RU2703177C2 (ru) * | 2014-12-19 | 2019-10-15 | Сосьете Де Продюи Нестле С.А. | Питание для младенцев с гидролизованным белком, ионным кальцием и пальмитиновой кислотой |
RU2703172C2 (ru) * | 2014-12-19 | 2019-10-15 | Сосьете Де Продюи Нестле С.А. | Питание для младенцев с гидролизованным белком и пальмитиновой кислотой |
US11877587B2 (en) | 2014-12-19 | 2024-01-23 | Societe Des Produits Nestle S.A. | Infant nutrition with hydrolysed protein, ionic calcium and palmitic acid |
NL2019906B1 (en) * | 2017-11-14 | 2019-05-20 | Ausnutria Hyproca B V | Composition comprising a2 b-casein and a vegetable fat mixture |
WO2019098823A1 (en) * | 2017-11-14 | 2019-05-23 | Ausnutria Hyproca B.V. | Composition comprising a2 b-casein and a vegetable fat mixture |
DE102019205767A1 (de) * | 2019-04-23 | 2020-10-29 | Beiersdorf Ag | Deodorant- oder Antitranspirantzusammensetzung |
Also Published As
Publication number | Publication date |
---|---|
CN105962374A (zh) | 2016-09-28 |
CN101686726A (zh) | 2010-03-31 |
UA99614C2 (ru) | 2012-09-10 |
RU2009144036A (ru) | 2011-06-20 |
WO2008138821A1 (de) | 2008-11-20 |
RU2468610C2 (ru) | 2012-12-10 |
EP2152101A1 (de) | 2010-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2023100665A (ja) | 栄養製品 | |
DE102007022694A1 (de) | Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme | |
DE69816568T2 (de) | Neue verwendung von phospholipiden tierischen ursprungs in der therapie und/oder schonkost | |
DE3151245C2 (ru) | ||
US20200108040A1 (en) | Agent for improving brain function and agent for preventing or treating cognitive impairment | |
CN101325882A (zh) | 包含长链多不饱和脂肪酸的营养补充剂 | |
DE10324548A1 (de) | Diätisches Lebensmittel bei einer gewichtskontrollierenden bzw. gewichtsreduzierenden Ernährung | |
EA025117B1 (ru) | Способ улучшения развития нервной системы и/или мозга плода или ребёнка, находящегося на грудном вскармливании | |
DE102007004781A1 (de) | Verwendung von Guanidinoessigsäure(-Salzen) zur Herstellung eines gesundheitsfördernden Mittels | |
MX2013005939A (es) | Uso de composiciones nutricionales que incluyen lactoferrina en la estimulacion de celulas inmunes. | |
DE102005033630A1 (de) | Calcium-Peptid-Komponente | |
DE602004005821T2 (de) | Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis | |
AT515884A2 (de) | Zubereitung in Form eines Riegels | |
DE69834663T3 (de) | Methode zur Änderung der Nährmittelzusammenstellung der Milch die durch milchspendende Tiere abgesondert wird | |
DE212011100215U1 (de) | Ernährungsprodukt, umfassend ein Biguanid | |
DE10217557A1 (de) | Funktionsnahrungsmittel enthaltend eine Phospholipid-haltige stabile Matrix | |
EP2926669B1 (de) | Kreatin-Proteinmatrix sowie Verfahren zur Herstellung dieser Matrix | |
DE10066034A1 (de) | Speiseeis mit Zusatz von Muskelaufbaupräparaten und Vitaminen | |
WO2019139032A1 (ja) | 癌患者筋肉量減少抑制組成物 | |
DE202006019504U1 (de) | Eiweißpräparat | |
EP2259789A2 (de) | Pharmazeutisches kit aus einer öl/wasser-emulsion und einer festen zusammensetzung | |
DE19510765A1 (de) | Verfahren zur Herstellung von Frühgeborenen-, Säuglings- und Diätnahrung | |
DE19534602A1 (de) | Verwendung von Threonin zur Behandlung der Phenylketonurie | |
DE19654614C2 (de) | Verfahren zur Herstellung von biologisch hochwertigen Sauermilcherzeugnissen | |
Kashyap | Ankit Kashyap, AK Santra, OP Dinani, Nishma Singh, Rupal Pahak, Subhrajit Das and Anupam Soni |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OP8 | Request for examination as to paragraph 44 patent law | ||
R079 | Amendment of ipc main class |
Free format text: PREVIOUS MAIN CLASS: A23L0001300000 Ipc: A23L0033120000 |
|
R002 | Refusal decision in examination/registration proceedings | ||
R003 | Refusal decision now final |